Catalyst Wire Dossier Catalyst Wire Dossier

Veregen 10% Ointment

sinecatechin · Aresus Pharma GmbH
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Veregen 10% Ointment, covering 2025-08-22 to 2025-08-22. Get the full timeline:

Most recent: Clinical Trial Update: Phase 3 - Evaluation of Veregen® 10% Ointment as New Herbal Topical Treatment for Actinic Keratosis [Phase 3]

See pricing